Exentis Secures $22 Million in US Additive Manufacturing Sales
Exentis Group AG, based in Switzerland, has emerged as a leader in the growing field of large-scale additive manufacturing. The company’s proprietary 3D screen printing technology enables high-volume production with unparalleled material flexibility. This innovation has positioned Exentis as a forerunner in industries such as pharmaceuticals, new energy, and ultra-fine industrial parts manufacturing.
Unlike traditional 3D printing, Exentis’s approach integrates mass production capabilities with a completely free choice of materials, including active pharmaceutical ingredients. These capabilities offer unique advantages for producing customized drug delivery profiles and precise industrial components. At the same time, the process emphasizes sustainability, minimizing waste and energy use to meet the demands of eco-conscious industries.
Breaking ground in the US market
In a significant stride forward, Exentis reported sales of nine 3D production systems in the final quarter of 2024, amounting to $22 million. This brought their total US sales to ten systems this year, effectively doubling their footprint in this critical market. The US, widely regarded as the global leader in industrial additive manufacturing, is a strategic target for companies aiming to scale operations and capture new opportunities.
Gürsel Demircali, Chief Commercial Officer of Exentis, highlighted the importance of this milestone, stating that the company’s technology platform is gaining traction in the US market. “Our platform’s sustainability and material flexibility are setting new standards in additive manufacturing,” he noted, underscoring the growing appeal of Exentis’s innovative solutions.
Leveraging innovation: Applications and industries
Exentis’s groundbreaking 3D screen printing technology is tailored for high-volume applications across a range of industries, making it a versatile solution for advanced manufacturing needs. One of the most prominent areas of application is the pharmaceutical industry, where Exentis’s systems are used to produce customized tablets with precise drug delivery profiles. This capability is especially critical for personalized medicine, which requires highly specific formulations to meet individual patient needs.
The technology is also revolutionizing industrial manufacturing by enabling the creation of ultra-fine components for energy systems and other high-precision applications. Unlike conventional additive manufacturing methods, Exentis’s approach ensures scalability without sacrificing quality or material integrity. By offering complete freedom in material selection, the platform provides unmatched flexibility, opening the door to innovation in materials science and product design.
Industries such as renewable energy, automotive, and consumer electronics are also exploring the potential of Exentis’s solutions, which are designed to meet the demands of modern production cycles.
Sustainability and patent-backed technology
A key differentiator for Exentis is its focus on sustainability. The company’s manufacturing processes are designed to minimize waste, reduce energy consumption, and enable the efficient use of raw materials. These attributes resonate strongly with industries under increasing pressure to adopt greener practices and meet global environmental standards.
Exentis’s technological platform is further bolstered by a comprehensive portfolio of patents, with approximately 5,600 patent claims covering its innovations. This robust intellectual property framework not only protects the company’s technology but also positions it as a leader in a competitive market. By securing patents across critical aspects of 3D screen printing, Exentis ensures that its unique approach remains at the forefront of additive manufacturing advancements.
Exentis Group AG’s recent success in the US market signals a larger strategy to expand its global footprint and drive adoption of its 3D screen printing technology across key industries. The strategic emphasis on sustainability will remain central to Exentis’s vision.
Sources:
To keep up-to-date with our latest manufacturing news, subscribe to our newsletter today.